2.19
+1.314(+150.00%)
Currency In USD
| Previous Close | 0.88 |
| Open | 1.57 |
| Day High | 2.66 |
| Day Low | 1.37 |
| 52-Week High | 10.4 |
| 52-Week Low | 0.67 |
| Volume | 405.5M |
| Average Volume | 493,072 |
| Market Cap | 11.1M |
| PE | -0.39 |
| EPS | -5.56 |
| Moving Average 50 Days | 1.2 |
| Moving Average 200 Days | 2.78 |
| Change | 1.31 |
If you invested $1000 in Beyond Air, Inc. (XAIR) since IPO date, it would be worth $37.12 as of January 14, 2026 at a share price of $2.19. Whereas If you bought $1000 worth of Beyond Air, Inc. (XAIR) shares 5 years ago, it would be worth $16.85 as of January 14, 2026 at a share price of $2.19.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
GlobeNewswire Inc.
Yesterday at 12:30 PM GMT
Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA Orphan Drug designa
Beyond Air® Appoints Dan Moorhead as Chief Financial Officer
GlobeNewswire Inc.
Dec 30, 2025 12:30 PM GMT
GARDEN CITY, N.Y., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve th
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
GlobeNewswire Inc.
Dec 17, 2025 12:30 PM GMT
Distribution network coverage expanded to a total of 39 countriesGARDEN CITY, N.Y., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company f